Biomarkers in the drug development process: report...[Regul Toxicol Pharmacol. 2008]

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Regul Toxicol Pharmacol. 2008 Nov;52(2):75-6. Epub 2008 May 11. Links

Biomarkers in the drug development process: report from workshop discussions.

van Gool AJ, Spindler P, Harpur E, Bounous D, Olejniczak K, van de Klundert FA, Haenen B.

Chair Organon Biomarker Platform, Target Discovery Unit Oss, NV Organon, Part of Schering-Plough Corporation, Molenstraat 110, 5340 BH Oss, The Netherlands.

PMID: 18556099 [PubMed - indexed for MEDLINE]

A prototypical process for creating evidentiary standards for biomarkers and diagnostics.
Clin Pharmacol Ther. 2008 Feb; 83(2):368-71. Epub 2007 Dec 19.

[Clin Pharmacol Ther. 2008]
ReviewValidation of analytic methods for biomarkers used in drug development.
Clin Cancer Res. 2008 Oct 1; 14(19):5967-76.

[Clin Cancer Res. 2008]
Biomarkers: a valuable tool in clinical research and medical practice.
IDrugs. 2007 Jun; 10(6):395-8.

[IDrugs. 2007]
Developing the evidence base for applying pharmacogenomics: proceeds from DIA Workshop IV--Breakout Session 1.
Pharmacogenomics. 2009 Jan; 10(1):117-25.

[Pharmacogenomics. 2009]
ReviewAlternative strategies in drug development: clinical pharmacological aspects.
Int J Clin Pharmacol Ther. 1999 Dec; 37(12):575-83.

[Int J Clin Pharmacol Ther. 1999]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

Biomarkers in the drug development process: report from workshop discussions.Biomarkers in the drug development process: report from workshop discussions.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show

Biomarkers in the drug development process: report from workshop discussions.

Related articles

Recent Activity